Cancer gene-therapy: clinical trials

Area of Science:

• Oncology
• Molecular Biology
• Virology

Background:

• Gene therapy for cancer seeks to selectively eliminate tumor cells while preserving healthy tissues.
• Effective gene therapy requires targeted delivery and specific cytotoxic action against cancer cells.

Purpose of the Study:

• To explore the potential of gene therapy as a cancer treatment strategy.
• To review various gene therapy approaches, including enzyme-pro-drug systems, genetic correction, and immunotherapy.
• To highlight the critical role of viral vectors in achieving targeted gene expression and tumor cell lysis.

Main Methods:

• Review of laboratory-based gene therapy strategies for cancer treatment.
• Discussion of viral vector engineering for selective tumor cell targeting and replication.
• Examination of different therapeutic approaches: enzyme-pro-drug activation, genetic mutation correction, and immune response stimulation.

Main Results:

• Promising laboratory results have been achieved with various gene therapy strategies.
• Viral vectors demonstrate potential for targeted transduction of tumor cells.
• Engineered viruses can selectively replicate within cancer cells, leading to their lysis.

Conclusions:

• Viral vectors are key to successful gene therapy, enabling targeted gene delivery and expression.
• Engineering viruses for selective replication and lysis of cancer cells offers a promising therapeutic avenue.
• Translating these viral vector-based strategies into effective clinical cancer therapies remains a significant challenge.